Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025)
Bausch Health Companies' (BHC) quarterly Asset Writedowns and Impairment came in at $7.0 million in Q4 2025, down 69.57% year-on-year from $23.0 million in Q4 2024, and up 600.0% quarter-over-quarter from $1.0 million in Q3 2025.
Bausch Health Companies (BHC) Asset Writedowns and Impairment (2009 - 2025) Analysis & Trends
Bausch Health Companies has disclosed Asset Writedowns and Impairment across 12 years of filings, most recently posting $7.0 million for Q4 2025.
- Asset Writedowns and Impairment for Q4 2025 came in at $7.0 million, down 69.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $8.0 million (down 72.41% YoY), and the FY2025 annual result was $8.0 million, down 72.41% from the prior year.
- Asset Writedowns and Impairment came in at $7.0 million for Q4 2025 at Bausch Health Companies, up from $1.0 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $148.0 million in Q1 2021 to a low of $1.0 million in Q3 2022.
- The 5-year median for Asset Writedowns and Impairment is $8.0 million (2022), against an average of $22.7 million.
- Across the five-year window, Asset Writedowns and Impairment soared 4600.0% in 2021 and sank 94.59% in 2022, its largest moves.
- Bausch Health Companies' Asset Writedowns and Impairment stood at $21.0 million in 2021, then slumped by 95.24% to $1.0 million in 2022, then surged by 300.0% to $4.0 million in 2023, then jumped by 475.0% to $23.0 million in 2024, then tumbled by 69.57% to $7.0 million in 2025.
- The last three Asset Writedowns and Impairment figures came in at $7.0 million (Q4 2025), $1.0 million (Q3 2025), and $23.0 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Bausch Health Companies | 1.92 Bn | 1.58 Bn | 2.48 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.00 Mn |
| Dec 31, 2025 | 7.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Dec 31, 2024 | 23.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 5.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Mar 31, 2024 | 1.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Sep 30, 2023 | 4.00 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Jun 30, 2023 | 37.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Sep 30, 2022 | 1.00 Mn |
| Jun 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 6.00 Mn |